Orthopoxvirus Targets for the Development of New Antiviral Agents

Antiviral Research - Netherlands
doi 10.1016/j.antiviral.2012.02.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

E1 and E2 Viral Proteins as Therapeutic Targets for Development of Antiviral Agents

2019English

Antiviral Agents in Development for Zika Virus Infections

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2019English

Recent Advances in Process Development of Antiviral Agents Targeting the Influenza Virus: Amantadine-RemantadineDerived Pharmaceutical Agents

Open Access Journal of Pharmaceutical Research
2018English

Revealing the Characteristics of Antiviral Agents

Uirusu. Journal of virology
Medicine
2017English

Polysaccharides as Antiviral Agents: Antiviral Activity of Carrageenan.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1987English

Targeting GIRK Channels for the Development of New Therapeutic Agents

Frontiers in Pharmacology
Pharmacology
2011English

Tannins as Antiviral Agents

2020English

Review HCV Antiviral Resistance: The Impact of in Vitro Studies on the Development of Antiviral Agents Targeting the Viral NS5B Polymerase

Antiviral Chemistry and Chemotherapy
MedicineVirologyDrug DiscoveryPharmacology
2005English

Synthesis of ThymoquinoneArtemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial Agents

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy